19-7633434-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_174895.3(PCP2):c.24G>A(p.Thr8=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.341 in 1,575,464 control chromosomes in the GnomAD database, including 94,726 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.29 ( 7063 hom., cov: 33)
Exomes 𝑓: 0.35 ( 87663 hom. )
Consequence
PCP2
NM_174895.3 synonymous
NM_174895.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.0410
Genes affected
PCP2 (HGNC:30209): (Purkinje cell protein 2) Predicted to enable guanyl-nucleotide exchange factor activity. Predicted to be involved in regulation of catalytic activity. Predicted to act upstream of or within rhodopsin mediated signaling pathway. Predicted to be located in neuronal cell body. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.78).
BP6
Variant 19-7633434-C-T is Benign according to our data. Variant chr19-7633434-C-T is described in ClinVar as [Benign]. Clinvar id is 403501.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.041 with no splicing effect.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.363 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PCP2 | NM_174895.3 | c.24G>A | p.Thr8= | synonymous_variant | 1/4 | ENST00000311069.6 | NP_777555.1 | |
PCP2 | XM_024451346.2 | c.187G>A | p.Gly63Arg | missense_variant | 1/5 | XP_024307114.1 | ||
STXBP2 | NM_001414484.1 | c.-60+2588C>T | intron_variant | NP_001401413.1 | ||||
PCP2 | XM_006722639.4 | c.-60-604G>A | intron_variant | XP_006722702.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PCP2 | ENST00000311069.6 | c.24G>A | p.Thr8= | synonymous_variant | 1/4 | 1 | NM_174895.3 | ENSP00000310585 | A1 |
Frequencies
GnomAD3 genomes AF: 0.290 AC: 44039AN: 151720Hom.: 7056 Cov.: 33
GnomAD3 genomes
AF:
AC:
44039
AN:
151720
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.297 AC: 55860AN: 187902Hom.: 8923 AF XY: 0.304 AC XY: 30620AN XY: 100584
GnomAD3 exomes
AF:
AC:
55860
AN:
187902
Hom.:
AF XY:
AC XY:
30620
AN XY:
100584
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.346 AC: 492828AN: 1423624Hom.: 87663 Cov.: 39 AF XY: 0.345 AC XY: 243371AN XY: 704550
GnomAD4 exome
AF:
AC:
492828
AN:
1423624
Hom.:
Cov.:
39
AF XY:
AC XY:
243371
AN XY:
704550
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.290 AC: 44059AN: 151840Hom.: 7063 Cov.: 33 AF XY: 0.290 AC XY: 21564AN XY: 74236
GnomAD4 genome
AF:
AC:
44059
AN:
151840
Hom.:
Cov.:
33
AF XY:
AC XY:
21564
AN XY:
74236
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
873
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Mar 29, 2016 | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: MAF - |
not provided Benign:1
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at